Medicare Scraps Obesity Drug Pilot After Insurer Pushback; Amazon Launches GLP-1 Access Program
The Trump administration's Medicare obesity drug pilot was abandoned after insurers declined to participate. Meanwhile, Amazon's One Medical is launch...
The Trump administration's Medicare obesity drug pilot was abandoned after insurers declined to participate. Meanwhile, Amazon's One Medical is launch...
Amazon has expanded access to Eli Lilly’s new GLP-1 weight loss pill, Foundayo, through its One Medical kiosks and same-day delivery services. The pil...